Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Houtou Jianweiling Tablet in Chronic Non-Atrophic Gastritis
NCT04672018Phase 2Completed
- Sponsor
- University of Karachi
- Start
- Nov 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Houtou Jianweiling in chronic non-atrophic gastritis, sponsored by University of Karachi. Started Nov 2022; status: completed.
02
Drugs
Houtou Jianweiling
03
Conditions
chronic non-atrophic gastritis
Beyond the preview
Go deeper on NCT04672018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04672018.